Search Tag: breast cancer
2022 03 Oct
Tennis Legend Martina Navratilova Joins Hologic to Highlight Importance of Regular Screenings Hologic, Inc. Chairman, President and CEO Steve MacMillan will ring the Nasdaq opening bell today to mark the beginning of Breast Cancer Awareness Month. This is the 16th time that Hologic, an innovative medical technology company and the pioneer...Read more
2022 20 Sep
As of 2021, breast cancer has become the most common cancer in women in the United States. Fortunately, advances in screening, diagnosis and treatment have increased women’s survival rate to 90%. But despite these advances, nearly two-thirds of women diagnosed with breast cancer experience long-term side effects from treatment or breast cancer itself....Read more
2022 09 Sep
Breast cancer is the second leading cause of cancer mortality in the U.K. The earlier breast cancer is detected, the easier it is to manage, and the more successful the treatment. It is important to regularly self-check all over the breast for abnormalities, including around the armpit areas and up to the collarbone. However, self-regulation...Read more
2022 13 Jul
Global Leader in Women's Health Highlights Importance of Timely and Accurate Diagnosis Hologic will showcase their comprehensive portfolio of breast and skeletal health solutions at the annual European Congress of Radiology (ECR) in Vienna, Austria from July 13-17. The pioneer behind 3D™ Mammography technology, Hologic will provide attendees...Read more
2022 13 Jul
Hologic has partnered with other forward-thinking organizations to drive change that will impact women's lives for generations. This includes ALL women, regardless of race, caste or creed. Statistics show that Hispanic women are 40% more likely to be diagnosed with cervical cancer and 30% more likely to die from it than non-Hispanic white women....Read more
2022 21 Jun
New findings published in Cancer Epidemiology Biomarkers & Prevent show significant differences in the accuracy of diagnostic mammograms across racial and ethnic groups, with variation observed in several measures of diagnostic performance. Several studies have already established that racial disparities exist in breast cancer. Multiple socioeconomic...Read more
2022 09 May
This Pfizer-sponsored study used de-identified data derived from the Flatiron Health Analytic Database in a retrospective observational study to demonstrate palbociclib (PAL) combined with an aromatase inhibitor (AI) is an effective first-line therapy for treating metastatic breast cancer. Hormone receptor-positive/human epidermal growth factor...Read more
2022 27 Apr
Hologic, Inc.announced today that the American Society of Clinical Oncology (ASCO) has published an update which expands the utility of Breast Cancer Index™ (BCI) within its Clinical Practice Guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.” Specifically, ASCO now recognizes BCI as the only genomic test...Read more
2022 20 Apr
Ralph Highnam, founder, transitions from Chief Executive Officer to Chief Science & Innovation Officer Teri Thomas, NZ-based, Epic veteran appointed Chief Executive Officer Appointments reflect pivotal inflection point in both artificial intelligence innovation and commercial opportunities Volpara Health has announced key changes to...Read more
2022 13 Sep
Find International Cambridge Conference on Breast Cancer Imaging on Social Media Read more
2022 14 Feb
Cervical smear tests one day could be used to detect early breast and ovarian cancer. A European research team recently published in Nature Communications an epigenetic signature for breast and ovarian cancer that can be easily assayed in cervical smear samples. DNA methylation is an epigenetic mechanism to control gene expression. Greater methylation...Read more
2022 08 Feb
Over time, digital breast tomosynthesis (DBT) has shown superior sensitivity to conventional 2D digital mammography (DM) in breast cancer detection. Despite widespread clinical adoption, there is little evidence that this translates to improved clinical outcomes. Determining its effect on breast cancer mortality would require data spanning at least...Read more
2022 08 Feb
A new study from Australia found that 41% of screen-detected breast cancers occurred in women with no recorded risk factors. Globally and in Australia, there’s been interest in risk-stratified breast screening to improve benefits while reducing screening-associated harms.Increasing screening frequency or more sensitive imaging would be used for...Read more
2022 31 Jan
World Cancer Day is an initiative of the Union for International Cancer Control (UICC). Observed every 4 February since 2000, its goal is raising worldwide awareness, improving education, and catalysing personal, collective, and government action to reduce preventable cancer deaths and increase equitable access to cancer care. Cancer kills nearly...Read more
2022 13 Jan
Triple-Negative Breast Cancers (TNBCs) are more challenging to treat because they are not driven by estrogen receptors, progesterone receptors, or excess HER2 protein, typical targets for breast cancer therapeutics. Thus no standard therapy has shown proven efficacy for treating this patient population. Furthermore, this group of patients, which account...Read more
2022 11 Jan
Cleveland Clinic researchers along with Anixa Biosciences have initiated a phase 1 clinical trial to test a vaccine intended to prevent triple-negative breast cancers (TNBC). This trial is a first of its kind. TNBCs are named so because they test negative for estrogen receptors, progesterone receptors, and excess HER2 protein. Since these are...Read more
2021 01 Nov
University of Michigan researchers in Ann Arbor examined financial hardship among U.S. women during and after pregnancy, which included the prevalence of cost-related unmet healthcare needs, unaffordable healthcare, and general financial stress. The study examined financial hardship in 3509 peripartum women, aged 18 to 45 years, who participated...Read more
2021 25 Oct
Canadian researchers at Sunnybrook Health Sciences Centre, safely delivered trastuzumab antibody therapy to breast cancer brain metastases using magnetic resonance (MR)-guided focused ultrasound. This study provides the first visual confirmation that focused ultrasound can improve the delivery of targeted antibody therapy across the blood-brain barrier...Read more
2021 14 Oct
Major breast cancer charities worldwide annually celebrate October as “Breast Cancer Awareness Month.” This campaign began in 1985 as a partnership between the American Cancer Society and Imperial Chemical Industries’ bio sciences division (now part of AstraZeneca) to raise awareness and funds for researching causes, prevention, diagnosis, treatments,...Read more
2021 08 Oct
The 15 most prevalent cancers incurred a cost of $156.2 billion in 2018. Breast cancer patients contributed to the highest number of services and spending. Almost 20% of US cancer spending was on radiology Although how to deliver quality but affordable care to US patients requiring cancer treatment has been widely debated, the specific...Read more
2021 18 Aug
The ongoing coronavirus pandemic has taken a tremendous toll on global humanity, upending life as we know it and resulting in millions of lives lost across the world. In order to handle and best serve the constant influx of COVID-19 patients, health care facilities all over Europe have had to make sacrifices and reallocate resources, leading to delays and...Read more
2021 02 Aug
Women are often the first line of defense when protecting their family’s health, but in doing so tend to put their concerns on the back burner. While ageing is a topic of concern for most women, few take the time to focus on themselves. Studies have proven that following these top health tips will extend and improve women’s lives expodentially, according...Read more
2021 16 Jul
SAVING LIVES, MINIMIZING INVASIVE TREATMENTS “It’s an undisputed fact, and I don’t think anyone would disagree, that annual screening mammograms saves the most lives,” says Dr. Harriet Borofsky of Mills-Peninsula, one of five radiologists featured in this short video: Why Mammography ? Unfortunately, according to Dr. Matthew Covington of...Read more
2021 16 Jul
Four radiologists share their passion for good breast health—the key to detecting cancer at its earliest, most treatable stage. Hologic has made remarkable strides in the fight against breast cancer. When we introduced the first 3D mammography™ system on the market in 2011, we transformed radiologists’ ability to detect breast cancer earlier...Read more